TickerGuard
Buy Day today: Poor (44) Weak market breadth · major macro event coming up
MBX

MBX Biosciences, Inc.

Healthcare · Biotechnology

57.90$ -6.6% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement MBX
Line item 2022 2023 2024 2025
+180.4% +55.4% +1.6%
+33.4% +101.2% +37.9%
+80.0% +59.1% +75.3%
+40.3% +93.1% +43.8%
-100.0%

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?